Whereas this dual role of TGFβ as a tumor suppressor and pro-tumorigenic factor is well understood in various model systems, it is less clear if and at which stage this switch from anti- to pro-tumorigenic activity of TGFβ occurs in human breast cancer. The gene discussed is TGFB1; the disease is breast carcinoma.